Evidence map›Paper›PMID 33647277›Full record

ArticleJournal of lipid research2021

Lipid remodeling in response to methionine stress in MDA-MBA-468 triple-negative breast cancer cells.

Stacey L Borrego, Johannes Fahrmann, Jue Hou, Da-Wei Lin, Bruce J Tromberg, Oliver Fiehn, Peter Kaiser

Open access · goldAbstract read
In one paragraph

Article in Journal of lipid research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Stacey L BorregoDepartment of Biological Chemistry, University of California, Irvine, Irvine, CA, USA.
Johannes FahrmannWest Coast Metabolomics Center, University of California, Davis, Davis, CA, USA; Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jue HouDepartment of Biomedical Engineering, University of California, Irvine, Irvine, CA, USA.
Da-Wei LinDepartment of Biological Chemistry, University of California, Irvine, Irvine, CA, USA.
Bruce J TrombergDepartment of Biomedical Engineering, University of California, Irvine, Irvine, CA, USA; National Institute of Biomedical Imaging and Bioengineering, Bethesda, MD, USA.
Oliver FiehnWest Coast Metabolomics Center, University of California, Davis, Davis, CA, USA.
Peter KaiserDepartment of Biological Chemistry, University of California, Irvine, Irvine, CA, USA. Electronic address: pkaiser@uci.edu.
University of California, Irvine · USUniversity of California, Davis · US

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Melanie Funes · 1994 to 2026
$57.9M
West Coast Central Comprehensive Metabolomics Resource Core (WC3MRC)U24DK097154 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FIEHN, OLIVER · 2012 to 2017
$9.9M
Molecular concepts that monitor methionine metabolismR01GM128432 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI KAISER, PETER · 2018 to 2021
$1.3M
Methionine Dependency of CancerR21CA242270 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI KAISER, PETER · 2019 to 2020
$370k
NCI NIH HHS P30 CA062203NCI NIH HHS R21 CA242270NIDDK NIH HHS U24 DK097154NIGMS NIH HHS R01 GM128432
6 · The paper itself

Abstract

Methionine (Met) is an essential amino acid and critical precursor to the cellular methyl donor S-adenosylmethionine. Unlike nontransformed cells, cancer cells have a unique metabolic requirement for Met and are unable to proliferate in growth media where Met is replaced with its metabolic precursor, homocysteine. This metabolic vulnerability is common among cancer cells regardless of tissue origin and is known as "methionine dependence", "methionine stress sensitivity", or the Hoffman effect. The response of lipids to Met stress, however, is not well-understood. Using mass spectroscopy, label-free vibrational microscopy, and next-generation sequencing, we characterize the response of lipids to Met stress in the triple-negative breast cancer cell line MDA-MB-468 and its Met stress insensitive derivative, MDA-MB-468res-R8. Lipidome analysis identified an immediate, global decrease in lipid abundances with the exception of triglycerides and an increase in lipid droplets in response to Met stress specifically in MDA-MB-468 cells. Furthermore, specific gene expression changes were observed as a secondary response to Met stress in MDA-MB-468, resulting in a downregulation of fatty acid metabolic genes and an upregulation of genes in the unfolded protein response pathway. We conclude that the extensive changes in lipid abundance during Met stress is a direct consequence of the modified metabolic profile previously described in Met stress-sensitive cells. The changes in lipid abundance likely results in changes in membrane composition inducing the unfolded protein response we observe.

Indexed as

MethionineTriple Negative Breast NeoplasmsCell Line, TumorFemaleHumansLipid MetabolismStress, PhysiologicalMethioninecancer metabolismfatty acid metabolismhomocysteinelipid dropletslipid metabolismmethioninemethionine stressphospholipidstriglycerides

Identifiers

PMID33647277
PMCPMC8042402
OpenAlexW3134377822

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.